Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Cell Communication and Signaling : CCS|October 3, 2013
Sulindac activates NF-κB signaling in colon cancer cellsDessislava Mladenova, Laurent Pangon, Nicola Currey, et al.
Molecular and Cellular Biology|July 1, 2009
Estrogen regulation of cyclin E2 requires cyclin D1 but not c-MycC Elizabeth Caldon, C Marcelo Sergio, Judith Schütte, et al.
Cancer Research|August 9, 2003
p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cellsJason S Carroll, Danielle K Lynch, Alexander Swarbrick, et al.
Cell Division|March 6, 2015
Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cellsSamuel Rogers, Brian S Gloss, Christine S Lee, et al.
Anticancer Research|January 4, 2012
Mutated in colorectal cancer protein modulates the NFκB pathwayNicholas D Sigglekow, Laurent Pangon, Tilman Brummer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Cyclin E expression and outcome in pancreatic ductal adenocarcinomaDavid A Skalicky, James G Kench, Davendra Segara, et al.
Plos One|March 10, 2009
Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroupM Chehani Alles, Margaret Gardiner-Garden, David J Nott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongueRhonda A Kwong, Tuan V Nguyen, Ronaldo J Bova, et al.
Molecular Endocrinology (Baltimore, Md.)|August 23, 2003
The cyclin-dependent kinase inhibitor p27 (Kip1) regulates both DNA synthesis and apoptosis in mammary epithelium but is not required for its functional development during pregnancyElizabeth A Davison, Christine S L Lee, Matthew J Naylor, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patientsElena López-Knowles, Sarah J Zardawi, Catriona M McNeil, et al.
Pageof 8